rs200346970
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_004380.3(CREBBP):c.3611A>T(p.Tyr1204Phe) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000148 in 1,612,038 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004380.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- Rubinstein-Taybi syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- Rubinstein-Taybi syndrome due to CREBBP mutationsInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- Menke-Hennekam syndrome 1Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CREBBP | NM_004380.3 | c.3611A>T | p.Tyr1204Phe | missense_variant, splice_region_variant | Exon 19 of 31 | ENST00000262367.10 | NP_004371.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CREBBP | ENST00000262367.10 | c.3611A>T | p.Tyr1204Phe | missense_variant, splice_region_variant | Exon 19 of 31 | 1 | NM_004380.3 | ENSP00000262367.5 | ||
| CREBBP | ENST00000382070.7 | c.3497A>T | p.Tyr1166Phe | missense_variant, splice_region_variant | Exon 18 of 30 | 1 | ENSP00000371502.3 | |||
| CREBBP | ENST00000570939.2 | c.2216A>T | p.Tyr739Phe | missense_variant, splice_region_variant | Exon 14 of 23 | 5 | ENSP00000461002.2 | |||
| CREBBP | ENST00000573517.6 | c.-86A>T | upstream_gene_variant | 5 | ENSP00000460474.2 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152218Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000124 AC: 31AN: 249834 AF XY: 0.000170 show subpopulations
GnomAD4 exome AF: 0.000150 AC: 219AN: 1459820Hom.: 1 Cov.: 30 AF XY: 0.000158 AC XY: 115AN XY: 726246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000125 AC: 19AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74370 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Rubinstein-Taybi syndrome Uncertain:1
This sequence change replaces tyrosine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 1204 of the CREBBP protein (p.Tyr1204Phe). This variant is present in population databases (rs200346970, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with CREBBP-related conditions. ClinVar contains an entry for this variant (Variation ID: 133928). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CREBBP protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Benign:1
This variant is associated with the following publications: (PMID: 24728327) -
not specified Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at